Type 1 Diabetes Market Size is Estimated to Reach US$ 13.64 Bn by 2030, With a Growing CAGR of 7.6% Over the Forecast Period 2023-2030 | Research by SNS Insider
24 févr. 2023 09h00 HE
|
SNS Insider pvt ltd
New York, Feb. 24, 2023 (GLOBE NEWSWIRE) -- “The Type 1 Diabetes Market Size was valued at US$ 7.59 billion in 2022, and is projected to reach US$ 13.64 billion by 2030, with a growing CAGR of 7.6%...
Diabeloop and EOFlow Partner to Offer a Wearable AID With a Smartphone App
11 janv. 2023 23h31 HE
|
Diabeloop SA
PARIS, Jan. 11, 2023 (GLOBE NEWSWIRE) -- EOFlow Co., Ltd. (KOSDAQ: 294090) (EOFlow or the Company), a provider of wearable drug delivery systems, and Diabeloop, a leader in diabetes automated...
Beta Bionics Appoints Dr. Steven Russell as Chief Medical Officer in Preparation for the Commercial Launch of the iLet Bionic Pancreas System
04 janv. 2023 12h00 HE
|
Beta Bionics, Inc.
CONCORD, Mass., Jan. 04, 2023 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. — a clinical-stage medical technology company — announced the appointment of Steven Russell, MD, Ph.D., to the role of Chief...
Beta Bionics Appoints Sean Saint as CEO and Board Member
15 août 2022 16h00 HE
|
Beta Bionics, Inc.
Caution: The iLet® Bionic Pancreas and iLet Duo™ are investigational devices limited by Federal (or United States) law to investigational use. Not available for sale. CONCORD, Mass., Aug. 15, 2022 ...
Type 1 Diabetes Pipeline Landscape Analysis of 80+ Companies by DelveInsight
08 août 2022 13h00 HE
|
DelveInsight Business Research LLP
New York, USA, Aug. 08, 2022 (GLOBE NEWSWIRE) -- Type 1 Diabetes Pipeline Landscape Analysis of 80+ Companies by DelveInsight Type 1 Diabetes pipeline involves 80+ key companies continuously...
Increasing Diabetic Patient Pool to Push Sales of Insulin Storage Devices across Geographies: Fact.MR Study
01 août 2022 19h30 HE
|
FACT.MR
Seoul, South Korea, Aug. 02, 2022 (GLOBE NEWSWIRE) -- Sales of insulin storage devices across the world are predicted to increase at a CAGR of 8.1% across the forecast period (2022-2027). In 2022,...
vTv Therapeutics Announces Investment by CinRx Pharma
25 juil. 2022 07h00 HE
|
vTv Therapeutics Inc.
HIGH POINT, N.C., July 25, 2022 (GLOBE NEWSWIRE) -- vTv Therapeutics Inc. (Nasdaq: VTVT) today announced entry into agreements that include a $10 million investment by CinPax, LLC (“CinPax”), a...
The Insulin-Only Bionic Pancreas Pivotal Trial Showed Consistent Mean HbA1c Reductions Across a Variety of Subgroups at ADA’s 82nd Scientific Sessions
09 juin 2022 14h00 HE
|
Beta Bionics, Inc.
Caution: The iLet® Bionic Pancreas is an investigational device limited by Federal (or United States) law to investigational use. Not available for sale. The randomized Insulin-Only Bionic Pancreas...
Blood Glucose Monitoring Devices Market to reach $28.76 Billion in 2030 with a CAGR of around 7.92%
02 juin 2022 11h28 HE
|
STRATEGIC MARKET RESEARCH LLP
New York, United States, June 02, 2022 (GLOBE NEWSWIRE) -- Blood glucose monitoring is the utilization of a glucose meter for monitoring and identifying the overall concentration content of glucose...
Pivotal Trial Results of the iLet® Bionic Pancreas to Be Presented at the ADA’s 82nd Scientific Sessions
01 juin 2022 05h00 HE
|
Beta Bionics, Inc.
Caution: The iLet® Bionic Pancreas is an investigational device limited by Federal (or United States) law to investigational use. Not available for sale. Dr. Roy W. Beck will moderate a session: The...